| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $81.7M | -15.5% |
| Cost of Revenue | $33.8M | -16.2% |
| Gross Profit | $47.9M | -15.0% |
| R&D Expense | $19.7M | -9.8% |
| SG&A Expense | $69.3M | -15.9% |
| Operating Income | -$46.7M | +19.0% |
| Pre-tax Income | -$55.2M | +12.7% |
| Income Tax | $146K | +265.0% |
| Net Income | -$55.4M | +12.6% |
| EPS (Basic) | -$1.12 | +21.7% |
| EPS (Diluted) | -$1.12 | +21.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | -85.8% |
| Short-term Investments | $23.3M | — |
| Accounts Receivable | $13.8M | -18.9% |
| Inventory | $24.3M | +36.0% |
| Current Assets | $76.7M | -37.0% |
| Total Assets | $125.0M | -30.7% |
| Current Liabilities | $29.4M | -16.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.1M | +13.4% |
| Capital Expenditures | $2.5M | -32.8% |
| Investing Cash Flow | -$24.1M | -818.6% |
| Financing Cash Flow | -$3.2M | -105.6% |
| Free Cash Flow | -$46.6M | +14.7% |
| Long-term Debt |
| $76.2M |
| +1.2% |
| Total Liabilities | $117.4M | -7.3% |
| Stockholders' Equity | $7.6M | -85.9% |